Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.
Mellinghoff IK, Lu M, Wen PY, Taylor JW, Maher EA, Arrillaga-Romany I, Peters KB, Ellingson BM, Rosenblum MK, Chun S, Le K, Tassinari A, Choe S, Toubouti Y, Schoenfeld S, Pandya SS, Hassan I, Steelman L, Clarke JL, Cloughesy TF.
Mellinghoff IK, et al. Among authors: ellingson bm.
Nat Med. 2024 Jan;30(1):302. doi: 10.1038/s41591-023-02473-7.
Nat Med. 2024.
PMID: 37400643
Free PMC article.
No abstract available.